How do you want your Singulair be delivered? Choose here!

The Food and Drug Administration has issued an “early communication” to health care professionals regarding its review of the postmarketing reports it has received of behavior/mood changes, suicidality, and suicide in patients who have taken the asthma and allergy medication montelukast (Singulair).
At press time, the agency had declined to say how many repo…